Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mechanisms of disease: proatherogenic HDL--an evolving field.
Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fogelman AM. Navab M, et al. Among authors: fogelman am. Nat Clin Pract Endocrinol Metab. 2006 Sep;2(9):504-11. doi: 10.1038/ncpendmet0245. Nat Clin Pract Endocrinol Metab. 2006. PMID: 16957764 Review.
Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis.
Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Hough G, Wagner A, Nakamura K, Garber DW, Datta G, Segrest JP, Hama S, Fogelman AM. Navab M, et al. Among authors: fogelman am. Curr Opin Investig Drugs. 2003 Sep;4(9):1100-4. Curr Opin Investig Drugs. 2003. PMID: 14582455 Review.
The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.
Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N, Berliner JA, Lusis AJ, Fogelman AM. Navab M, et al. Among authors: fogelman am. J Lipid Res. 2004 Jun;45(6):993-1007. doi: 10.1194/jlr.R400001-JLR200. Epub 2004 Apr 1. J Lipid Res. 2004. PMID: 15060092 Free article. Review.
Anti-inflammatory properties of HDL.
Ansell BJ, Navab M, Watson KE, Fonarow GC, Fogelman AM. Ansell BJ, et al. Among authors: fogelman am. Rev Endocr Metab Disord. 2004 Dec;5(4):351-8. doi: 10.1023/B:REMD.0000045107.71895.b2. Rev Endocr Metab Disord. 2004. PMID: 15486468 Review. No abstract available.
An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice.
Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Wagner AC, Hama S, Hough G, Bachini E, Garber DW, Mishra VK, Palgunachari MN, Fogelman AM. Navab M, et al. Among authors: fogelman am. Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1932-7. doi: 10.1161/01.ATV.0000174589.70190.e2. Epub 2005 Jun 16. Arterioscler Thromb Vasc Biol. 2005. PMID: 15961700
The double jeopardy of HDL.
Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Hama S, Hough G, Bachini E, Grijalva VR, Wagner AC, Shaposhnik Z, Fogelman AM. Navab M, et al. Among authors: fogelman am. Ann Med. 2005;37(3):173-8. doi: 10.1080/07853890510007322. Ann Med. 2005. PMID: 16019715 Free article. Review.
The role of high-density lipoprotein in inflammation.
Navab M, Anantharamaiah GM, Fogelman AM. Navab M, et al. Among authors: fogelman am. Trends Cardiovasc Med. 2005 May;15(4):158-61. doi: 10.1016/j.tcm.2005.05.008. Trends Cardiovasc Med. 2005. PMID: 16099381 Review.
297 results